Evidence mapPaperPMID 16759299Full record

GuidelineDiabetic medicine : a journal of the British Diabetic Association2006

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

IDF Clinical Guidelines Task Force

Registry-linked trialAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Diabetic medicine : a journal of the British Diabetic Association, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03398356 (The Assessment of the Effect of Metformin and Its Serum Concentration on the Concentration of Substances Associated With the Production of Nitric Oxide in Patients With Impaired Carbohydrate Metabolism), which is not on this map. Cited by 162 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 8 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03398356 phase4completedstarted 2017, after this paper: background citation

The Assessment of the Effect of Metformin and Its Serum Concentration on the Concentration of Substances Associated With the Production of Nitric Oxide in Patients With Impaired Carbohydrate Metabolism

Ran2017Enrolled47Registered outcomes6Posted comparisons0ConditionsImpaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT), PrediabetesArmsMetformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2011
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Rosiglitazone RECORD study: glucose control outcomes at 18 months.Diabetic medicine : a journal of the British Diabetic Association · 2007 · on this map
    Trial

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

IDF Clinical Guidelines Task Force

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Clinical Guidelines Task Force of the International Diabetes Federation has created an evidence-based Global Guideline for the care of people with Type 2 diabetes around the world. The recommendations developed for three levels of care (standard, comprehensive, and minimal), which can be applied in settings with different resources, are presented here. The source document is published elsewhere.

Indexed as

Developed CountriesDeveloping CountriesCardiovascular DiseasesCost-Benefit AnalysisDiabetes ComplicationsDiabetes Mellitus, Type 2HumansInsulinPatient Education as TopicInsulin

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.